Iridex (IRIX) Net Income Growth (1y) (2011 - 2026)
Iridex (IRIX) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 125.69% |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn | 68.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 68.92% |
| Jan 3, 2026 | 77.86% |
| Sep 27, 2025 | 18.62% |
| Jun 28, 2025 | 62.90% |
| Mar 29, 2025 | 51.33% |
| Dec 28, 2024 | -112.38% |
| Sep 28, 2024 | -10.21% |
| Jun 29, 2024 | 3.15% |
| Mar 30, 2024 | -65.74% |
| Dec 30, 2023 | 4.96% |
| Sep 30, 2023 | 0.74% |
| Jul 1, 2023 | -23.43% |
| Apr 1, 2023 | 12.59% |
| Dec 31, 2022 | 591.46% |
| Oct 1, 2022 | 18.38% |
| Jul 2, 2022 | -260.88% |
| Apr 2, 2022 | -18.96% |
| Oct 2, 2021 | -25.95% |
| Jul 3, 2021 | 150.11% |
| Apr 3, 2021 | -21.74% |